症状性脑海绵状血管畸形的干预与保守治疗:前瞻性人群队列研究
该前瞻性人群队列研究纳入苏格兰1999-2010年诊断的306例脑海绵状血管畸形(CCM)患者,其中190例有症状。中位随访16年发现,CCM干预与持续性功能依赖或死亡(OHS≥3)相关(调整HR 2.66),并与明确相关的ICH/FND相关(调整HR 3.59),但与癫痫发作无关。
要点
- 症状性CCM干预与长期持续性功能依赖或死亡(OHS≥3)风险升高相关。
- 干预与随访期间明确相关的颅内出血或新发持续性局灶神经功能缺损相关。
- 干预与癫痫发作无显著关联,需随机对照试验进一步验证。
核心结论
- 对症状性CCM进行干预与长期随访中持续性功能依赖或死亡相关,可能由明确相关的ICH/FND解释。
研究设计与样本
- 基于人群的前瞻性队列研究,纳入苏格兰1999-2003年或2006-2010年新诊断的CCM患者,年龄≥16岁,共306例,其中190例有症状。
主要发现
- 中位随访16年(IQR 14-21,完整率95%),37例(19%)接受干预(35例显微手术切除,2例立体定向放射外科)。
- 干预组较保守治疗组更年轻(中位33岁 vs 43岁,p<0.001),以ICH起病更常见(49% vs 23%,p=0.002),脑干CCM更少(8% vs 24%,p=0.037)。
- 干预与OHS≥2的持续性功能损害或死亡无关联,但与OHS≥3相关(调整HR 2.66,95%CI 1.19-5.94,p=0.017)。
- 干预与随访中明确相关的ICH/FND相关(调整HR 3.59,95%CI 1.05-12.20,p=0.041)。
- 干预与随访中癫痫发作无关联(调整HR 1.56,95%CI 0.49-4.99,p=0.45)。
临床怎么用
- 对症状性CCM选择干预时应充分权衡长期功能依赖或死亡风险,尤其需关注ICH/FND相关风险。
- 研究结果提示需开展确定性随机对照试验以明确症状性CCM的最佳治疗策略。
局限性
- 干预为非随机分配,组间基线特征存在差异(如年龄、起病表现、CCM部位)。
- 干预例数较少(37例),部分结局事件数有限,估计精度受影响。
- 研究为观察性设计,可能存在残余混杂。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND OBJECTIVES: There is ongoing clinical equipoise regarding the optimal treatment strategy for symptomatic cerebral cavernous malformations (CCMs). The aim of this study was to estimate the causal effect between CCM intervention (microsurgical resection or stereotactic radiosurgery) and clinical outcomes during long-term follow-up. METHODS: This population-based cohort study included patients (aged 16 years or older) newly diagnosed with CCM using brain MRI or pathology in Scotland during 1999-2003 or 2006-2010. Using Cox regression analysis, we evaluated associations between CCM intervention (as a time-dependent covariate) and a primary outcome of persistent functional impairment or death (defined as at least 2 consecutive annual Oxford Handicap Scale [OHS] scores of ≥2, with sensitivity analysis of OHS scores ≥3), a composite of symptomatic intracranial hemorrhage or new persistent/progressive nonhemorrhagic focal neurologic deficit (ICH/FND) definitely/possibly related to CCM or CCM intervention, and epileptic seizure(s) definitely/possibly related to CCM during prospective follow-up. RESULTS: Among 306 patients with CCM, 190 were symptomatic (89 [47%] because of ICH/FND and 101 [53%] because of epileptic seizure(s), median age 40 years [interquartile range (IQR) 31-55], and 95 [50%] women). During a median follow-up of 16 years (IQR 14-21, completeness 95%), 37 (19%) patients underwent CCM intervention (n = 35 microsurgical resection and n = 2 stereotactic radiosurgery); they were younger (median 33 [26-40] vs 43 [32-59] years, p < 0.001), had presented with ICH more often (18/37 [49%] vs 35/153 [23%], p = 0.002), and had brainstem CCM less frequently (3/37 [8%] vs 36/153 [24%], p = 0.037) than those managed conservatively. CCM intervention was not associated with persistent functional impairment or death when analyzing OHS scores of ≥2 but was associated with OHS scores ≥3 (adjusted hazard ratio [HR] 2.66 [95% CI 1.19-5.94], p = 0.017). CCM intervention was associated with ICH/FND definitely related to CCM or CCM intervention during follow-up (adjusted HR 3.59 [95% CI 1.05-12.20], p = 0.041). CCM intervention was not associated with epileptic seizure(s) during follow-up (adjusted HR 1.56 [95% CI 0.49-4.99], p = 0.45). DISCUSSION: CCM intervention for symptomatic CCM was associated with persistent functional dependence or death during long-term follow-up. This may be explained by ICH/FND definitely related to CCM or CCM intervention. These findings should be investigated in a definitive randomized controlled trial.
引用
- Sandmann ACA, Verbaan D, Coutinho JM, et al. Intervention or Conservative Management for Symptomatic Cerebral Cavernous Malformations: A Prospective, Population-Based Cohort Study. Neurology. 2026. PMID: 42585604. doi:10.1212/WNL.0000000000218442
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。